Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.

Mednet Member

Radiation Oncology · UC San Diego

Micro-boost is my preferred strategy for dose escalation. The FLAME trial demonstrated a bDFS benefit (Kerkmeijer et al., PMID 33471548). The secondary analysis demonstrated reduced regional+distant metastasis and reduced local recurrence, as well (Groen et al., PMID 34953603). These benefits were ...